During the past decade, Gematologicheskj nauchnyj centr RAMN conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gematologicheskj nauchnyj centr RAMN" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gematologicheskj nauchnyj centr RAMN" are "Disease, Hodgkin" (2 trials), "Lymphoma, Large-Cell, Anaplastic" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Lymphoma, T-Cell, Cutaneous" (1 trials). Many other conditions were trialed in "Gematologicheskj nauchnyj centr RAMN" in a lesser frequency.

Most popular intervention types in "Gematologicheskj nauchnyj centr RAMN" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "brentuximab vedotin" (2 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gematologicheskj nauchnyj centr RAMN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Gematologicheskj nauchnyj centr RAMN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gematologicheskj nauchnyj centr RAMN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gematologicheskj nauchnyj centr RAMN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Gematologicheskj nauchnyj centr RAMN has several departments that took part in Clinical trials: "National Research Center for Hematology" - 13 trials